Total synthesis of cryptophycin analogues via a scaffold approach

Organic Letters

Volumn 8, Issue 14, 2006, Pages 2993-2996

  McCubbin, J Adam ^a   Maddess, Matthew L ^a   Lautens, Mark ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE; ANTIMITOTIC AGENT; CRYPTOPHYCIN; CYCLOPEPTIDE; DEPSIPEPTIDE; VINYL DERIVATIVE;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; CONFORMATION; ESTERIFICATION; STEREOISOMERISM; SYNTHESIS; X RAY CRYSTALLOGRAPHY;

ALDEHYDES; ANTIMITOTIC AGENTS; CRYSTALLOGRAPHY, X-RAY; DEPSIPEPTIDES; ESTERIFICATION; MOLECULAR CONFORMATION; MOLECULAR STRUCTURE; PEPTIDES, CYCLIC; STEREOISOMERISM; VINYL COMPOUNDS;

EID: 33746641274     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol0609356     Document Type: Article

References (52)

1. For a review on antimitotic agents, see: Li, Q.; Sham, H. L.; Rosenberg, S. Ann. Rep. Med. Chem. 1999, 34, 139.
2. (a) Jordan, M. A.; Wilson, L. Curr. Opin. Cell Biol. 1998, 10, 123.
3. (b) Giannakakou, P.; Sackett, D.; Fojo, T. J. Natl. Cancer Inst. 2000, 92, 182.
4. For reviews, see: (a) Tius, M. A. In Handbook of Environmental Chemistry; Gribble, G. W., Ed.; Springer: Berlin, 2003; p 265.;
5. (b) Hong, J.; Zhang, L. In Frontiers of Biotechnology and Pharmaceuticals; Zhao, K., Reiner J., Chen, S.-H., Eds.; Science Press New York Ltd.: New York, 2002; p 193.
6. (c) Li, T.; Shih, C. In Frontiers of Biotechnology and Pharmaceuticals; Zhao, K., Reiner, J., Chen, S.-H., Eds.; Science Press New York Ltd.: New York, 2002; p 172.
7. (d) Tius, M. A. Tetrahedron 2002, 58, 4343.
8. (e) Eggen, M.-J.; Georg, G. I. Med. Res. Rev. 2002, 22, 85.
9. (f) Shih, C.; Teicher, B. A. Curr. Pharm. Des. 2001, 7, 1259.
10. Nicolaou, K. C.; Dai, W.-M.; Guy, R. K. Angew. Chem., Int. Ed. Engl. 1994, 33, 15.
11. (a) Mitchison T., Kirschner, M. W. Nature 1984, 312, 237.
12. (b) Kirschner, M. W.; Mitchison, T. Nature 1986,324, 621.
13. (c) Avila, J. FASEB J. 1990, 4, 3284.
14. Wagner, M. M.; Paul, D. C.; Shih, C.; Jordan, M. A.; Wilson, L.; Williams, D. C. Cancer Chemother. Pharmacol. 1998, 115.
15. (a) Gottesman, M. M.; Pastan, I. Biochemistry 1993, 32, 385.
16. (b) Shen, D. W.; Fojo, A.; Chin, J. E.; Roninson, I. B.; Richert, N.; Pastan, I;; Gottesman, M. M. Science 1986, 232, 643.
17. (c) Gros, P.; Ben Neriah, Y.; Croop, J. M.; Housanman, D. E. Nature 1986, 323, 718.
18. Smith, C. D.; Zhang, X.; Mooberry, S. L.; Patterson, G. M. L.; R. Moore, E. Cancer Res. 1994, 54, 3779.
19. (a) Liang, J.; Moore, R. E.; Moher, E. D.; Munroe, J. E.; Alawar, R. S.; Hay, D. A.; Varie, D. L.; Zhang, T. Y.; Aikins, J. A.; Martinelli, M. J.; Shih, C.; Ray, J. E.; Gibson, L. L.; Vasudevan, V. Polin, L.; White, K.; Kushner, J.; Simpson, C.; Pugh, S.; Corbett, T. H. Invest. New Drugs 2005, 23, 213.
20. (b) Drew, L.; Fine, R. L.; Do, T. N.; Douglas, G. P.; Petrylak, D. P. Clin. Cancer Res. 2002, 8, 3922.
21. For recent total syntheses, see: (a) Danner, P.; Bauer, M.; Phukan, P.; Maier, M. E. Eur. J. Org. Chem. 2005, 11, 317.
22. (b) Tripathy, N. K.; Georg, G. I. Tetrahedron Lett. 2004, 45, 5309.
23. (c) Ghosh, A. K.; Bischoff, A. Eur. J. Org. Chem. 2004, 10, 2131.
24. (d) Vidya, R.; Eggen, M.-J.; Nair, S. K.; Georg, G. I.; Himes, R. H. J. Org. Chem. 2003, 68, 9687.
25. (e) Ghosh, A. K.; Swanson, L. J. Org. Chem. 2003, 68, 9823.
26. (a) Lautens, M.; Maddess, M. L.; Sauer, E. L.; Quellet, S. G. Org. Lett. 2002, 4, 83.
27. (b) Lautens, M.; Ouellet, S. G.; Raeppel, S. Angew. Chem., Int. Ed. 2000, 39, 4079.
28. Tsuji, J. In Palladium Reagents and Catalysis: New Perspectives for the 21st Century; Wiley: Chichester, U.K., 2004.
29. Mitra, A.; Sept, D. Biochemistry 2004, 43, 13955.
30. Lautens, M.; Maddess, M. L. Org. Lett. 2004, 6, 1883.
31. See Supporting Information for details.
32. For reviews, see: (a) Roberts, S. M. In Preparative Biotransformations; Wiley: Chichester, 1992-1997.
33. (b) Faber, K. In Biotransformations in Organic Chemistry, 3rd ed.; Springer: Weinheim, 1997.
34. (c) Wong, C.-H.; Whitesides, G. M. In Enzymes in Synthetic Organic Chemistry; Elsevier Science: New York, 1994.
35. (a) Taber, D. F.; Jiang, Q. J. Org. Chem. 2001, 66, 1876.
36. (b) Suh, Y. G.; Min, K.-H.; Lee, Y.-S.; Seo, S.-Y.; Kim, S.-H.; Park, H.-J. Tetrahedron Lett. 2002, 43, 3825.
37. (c) Zhu, B.; Panek, J. S. Eur. J. Org. Chem. 2001, 1701.
38. (d) Zhu, B.; Panek, J. S. Tetrahedron Lett. 2000, 12, 1863.
39. We first subjected the corresponding homoallylic homopropargylic alcohol to the resolution conditions of Taber (3 mass equiv AK, 60 °C, neat vinyl acetate) and observed that regardless of conversion, both the acetate and unreacted alcohol were racemic.
40. Stereochemistry was confirmed by comparison of HPLC traces of this alcohol and of the identical substrate prepared previously. See ref 11a
41. Currently, this acetate is not of sufficient optical purity to be useful in the preparation of cryptophycin analogues. We are investigating solutions to this problem.
42. Calculated according to: Chen, C.-S.; Fujimoto, Y.; Girdaukas, G.; Shi, C. J. J. Am. Chem. Soc. 1982, 104, 7294.
43. Absolute stereochemistry was proven by X-ray analysis of 22.
44. For details on the synthesis of 11, see Supporting Information.
45. This product was a single disasteromer, suggesting it was not formed by RCM with the internal olefin, followed by ROM/RCM to form the macrocycle.
46. Sonogashira, K.; Tohda, Y.; Hagihara, N. Tetrahedron Lett. 1975, 4467.
47. (a) Suzuki, A. J. Organomet. Chem. 2002, 653, 83.
48. (b) Miyaura, N.; Suzuki, A. Chem. Rev. 1995, 95, 2457.
49. int = 0.0665). The data frames were integrated and scaled using the Denzo-SMN package (Otwinowski, Z.; Minor, W. Methods Enzymol. 1997, 276, 307-326.).
50. -3. CCDC-288364 (22) contains the supplementary crystallographic data for this paper. These data can be obtained free of charge from the Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/ data_request/cif.
51. Brandes, B. D.; Jacobsen, E. N. J. Org. Chem. 1994, 59, 4378.
52. The configurations at the epoxide functionalities for 24maj and 24min have not yet been established.